Navigation Links
New Data Supports ConvaTec Negative Pressure Wound Therapy
Date:8/17/2009

ring solution that utilizes the application of negative pressure to a wound to promote healing by creating controlled tissue strain and removing excess fluid, including wound exudate. Every aspect of the System, from the wound interface to the user interface, has been designed to attain optimal clinical outcomes as well as a simplified application and monitoring system for patient care.

"This publication is just the beginning in the development of our clinical evidence base in support of this advanced NPWT technology," said Marcus Schabacker, Chief Scientific Officer, ConvaTec. "As the researcher noted, the acceptable levels of observed pain, exudate management, minimal bleeding and wound bed disruption are important factors for clinicians managing complex wounds and for the patients they care for - and validates the excellent response we have been receiving from our initial customers."

About ConvaTec

ConvaTec is a leading developer and marketer of innovative medical technologies that have helped improve the lives of millions of people worldwide. With four key business divisions - Ostomy Care, Wound Therapeutics, Continence and Critical Care and Infusion Devices - ConvaTec products support health care professionals from the hospital to the community health setting. From its headquarters in Skillman, New Jersey, the company oversees more than 8,000 employees in over 90 countries serving consumers and their health care professionals on six continents. For more information, please visit www.convatec.com.

Engenex is a registered trademark, and EasyRelease and Bio-Dome are trademarks of Boehringer Technologies L.P.

Our world is what we make of it is a trademark of ConvaTec Inc.

(C) 2009 ConvaTec Inc.

AP-007938-US

(1) Nease C. Using low pressure, negative pressure wound therapy for wound preparation and t
'/>"/>

SOURCE ConvaTec
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. New Study Supports Efficacy of Vagus Nerve Stimulation for Treatment-Resistant Depression
2. Cell Therapeutics, Inc. (CTI) Supports Panel Discussion on Women and Lung Cancer on Capitol Hill
3. Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer
4. Cost-Effectiveness Study Supports Use of EUFLEXXA(TM) by Rheumatologists for Pain Relief in Patients with Knee Osteoarthritis
5. New Data from the Framingham Heart Study Supports PAT Technology to Diagnose Early Cardiovascular Disease
6. Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as the First Combination Therapy for Initial Use in Patients Likely to Need Multiple Drugs to Achieve Their Blood
7. Interim Safety Analysis Supports Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma
8. Interim Analysis Supports Continuation of Cell Genesys VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer
9. FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
10. HUYA Bioscience Intl Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound; Data Supports Desirable Safety Profile
11. New Clinical Data Further Supports Chromium Picolinates Role in Enhancing Brain Activity in Older Adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... WASHINGTON , May 27, 2015 Doctors ... Innovation at Children,s National Health System ... to treat osteoid osteoma, a benign but ... young adults, using an experimental magnetic resonance-guided high-intensity focused ... and 10-year-old Niyati Shah , have been ...
(Date:5/27/2015)... 25, 2015 Research and Markets ... of the "2015 Strategies in the European ... This comprehensive five-country report contains 500 ... current suppliers and potential market entrants identify and ... testing market during the next five years. ...
(Date:5/27/2015)... DUBLIN , May 25, 2015 Research ... the "Global Rapid Medical Diagnostic Kits Market - ... Global market for Rapid Medical Diagnostic Kits, estimated ... in 2015 and further expected to maintain a CAGR ... projected US$27 billion by 2020. The global ...
Breaking Medicine Technology:Children's National first in US to destroy bone tumors with incisionless surgery 2Children's National first in US to destroy bone tumors with incisionless surgery 3Children's National first in US to destroy bone tumors with incisionless surgery 4European Coagulation Testing Market Strategies 2015 2Global Rapid Medical Diagnostic Kits Market - 2015-2020 Applications and Technologies Analysis of the $27 Billion Industry 2Global Rapid Medical Diagnostic Kits Market - 2015-2020 Applications and Technologies Analysis of the $27 Billion Industry 3Global Rapid Medical Diagnostic Kits Market - 2015-2020 Applications and Technologies Analysis of the $27 Billion Industry 4
... sleep onset, sleep maintenance ... total sleep time compared to placebo, BRIDGEWATER, N.J., June ... showed Ambien CR(R) (zolpidem,tartrate extended-release) CIV tablets 12.5 mg provided ... over 8,weeks in patients with co-morbid insomnia and major depressive ...
... of Roche and Ipsen,s First Once-Weekly Human ... Meeting -, NUTLEY, N.J., June 10 Roche ... been shown to provide,significant improvements in glucose control and ... safety and tolerability profile that,supports entry into Phase III. ...
Cached Medicine Technology:Ambien CR(R) (zolpidem tartrate extended-release) CIV Tablets Improved Insomnia and Daily Functioning in Patients with Co-Morbid Major Depressive Disorder 2Ambien CR(R) (zolpidem tartrate extended-release) CIV Tablets Improved Insomnia and Daily Functioning in Patients with Co-Morbid Major Depressive Disorder 3Ambien CR(R) (zolpidem tartrate extended-release) CIV Tablets Improved Insomnia and Daily Functioning in Patients with Co-Morbid Major Depressive Disorder 4Ambien CR(R) (zolpidem tartrate extended-release) CIV Tablets Improved Insomnia and Daily Functioning in Patients with Co-Morbid Major Depressive Disorder 5Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 2Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 3Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 4Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 5Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 6
(Date:5/27/2015)... Black Book Rankings, well known ... the multiple services and software industries, conducted a ... ranked Electronic Health and Medical Record software systems ... focus on implemented EHR users, Black Book reveals ... the highest scores in client experience among small ...
(Date:5/27/2015)... Texas (PRWEB) May 27, 2015 The ... of three FDA-approved dermal filler treatments in Abilene, Texas: ... to reduce the appearance of glabellar lines, better known ... Belotero Balance® is designed to treat smoker’s lines ... to the chin, while Radiesse® improves the appearance of ...
(Date:5/27/2015)... Coco Libre announced today that artists and audiences ... Organic Coconut Water to quench their thirst during the festival ... areas, artist greenrooms, corporate skyboxes and concessions areas at the ... on festival shuttle buses. , “We’re excited to have ... Director of Strategic Partnerships for Latitude 38 Entertainment, producer of ...
(Date:5/27/2015)... Arizona (PRWEB) May 27, 2015 Genius ... of their advanced programmatic marketing technology, they have boosted ... advertising support on a regional level for seven Utah-based ... marketing was through television and radio media. In 2014 ... with the help of Genius Monkey , shifted ...
(Date:5/27/2015)... Iowa (PRWEB) May 27, 2015 With ... away, a poll conducted during the "ACA - Controlling ... poll participants, 75% are currently in the process of ... over 15% were confidently prepared for the reporting mandates. ... shown during the webinar, those who are currently vetting ...
Breaking Medicine News(10 mins):Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 2Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 3Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 4Health News:The MedSpa at Hendrick Introduces Xeomin®, Belotero Balance® and Radiesse® Injectables 2Health News:Coco Libre Puts Organic Coconut Water on the Line-up at BottleRock Napa 2Health News:Genius Monkey Boosts Utah Honda Dealers Website Traffic 142% 2Health News:Employers are On Track for ACA Reporting According to Businessolver Poll 2
... the Sept.1 issue of the journal SLEEP ... is associated with increased sleep disturbances. Associations also were ... bullying has detrimental effects even when it is experienced ... of workplace bullying, with 11 percent of women and ...
... , , , ... ), a leading provider of kidney care services for those diagnosed ... one of the nation,s leading health care industry publications, named Kent ... Most Powerful People in Healthcare in 2009. , , ...
... , , , , ... Communications, Inc. (ECI), a full-service direct marketing agency staffed with seasoned ... www.starmsgroup.com ), has appointed Robin Raff to the position of ... www.ecihealthcare.com ). Raff reports directly to ECI CEO and ...
... WASHINGTON, Aug. 31 As Congress prepares to ... in at least 102 rallies and other events in 20 ... public health insurance option. , , Events ... day Congress returns to Washington, D.C.. They are taking place ...
... , , , ... MultiGEN Diagnostics Inc. has launched a novel multi-target DNA sequencing technology ... molecular diagnostics. , , "Until now, lack of ... forcing laboratories to adopt number of alternative methods such as traditional ...
... , , VENTURA, Calif., ... to give than to receive." However, when the gift one is ... moisturizer made with more than 97 percent organic aloe vera, receiving ... , Founded by Rinaldo and Lalla Brutoco, owners of ...
Cached Medicine News:Health News:Workplace bullying is associated with sleep disturbances 2Health News:Workplace bullying is associated with sleep disturbances 3Health News:DaVita CEO Kent Thiry Honored as One of Modern Healthcare's 100 Most Powerful People in Healthcare 2Health News:ECI Hires Robin Raff as Director of Strategy 2Health News:'Let's Get it Done!' From Coast to Coast, USAction Affiliates Rally This Week for Quality, Affordable Health Care 2Health News:Cost Effective Solution for Patient Testing: Introducing Comprehensive and Affordable Molecular Diagnosis With Verifiable Accuracy 2Health News:It's Better to Give Than to Receive 2Health News:It's Better to Give Than to Receive 3
... The Zeus Scientific, Inc. ENA Profile-6 ... for the detection of IgG antibodies to ... in human sera. When performed according to ... autoantibody profile may aid in the diagnosis ...
Inquire...
... Microalbumin Urine Controls are supplied ... liquid requiring no reconstitution or ... human urine, fortified to target ... creatinine. Preservatives including sodium azide ...
The K-ASSAY ITA Lyophilized Multi-Control Set is intended to be used as a consistent test sample of known concentration for monitoring the performance of K-ASSAY immunoturbidimetric assays for the li...
Medicine Products: